IP Library › Granted Patent US 11,596,589
Granted Patent B2
US 11,596,589 · App. 17/555,392 · Granted Mar 7, 2023

Compositions and method of use for hair straightening and shaping

Inventor: Justin Paloni (Cambridge, MA)
Assignee: Purvala Bioscience, Inc.
A61K8/64A61Q5/04C07K7/06C07K9/001C07K14/47
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,596,589
App. No.
17/555,392
Granted
Mar 7, 2023
Kind
B2
Abstract

Peptides are provided herein, wherein the peptide bearing one or more amino acid sequence differences relative to SEQ ID NO: 1, with the amino acid sequence differences comprising at least one cysteine replacement.

Claims (16)

1. A peptide comprising substitution of at least one amino acid of SEQ ID NO:1 with a cysteine, wherein the peptide comprises at least 50% sequence identity to SEQ ID NO:1.

2. The peptide of claim 1 , wherein at least one cysteine substitution occurs at any one or more of a glutamine amino acid position, a valine amino acid position, an alanine amino acid position, and a serine amino acid position.

3. The peptide of claim 1 , wherein the peptide forms an alpha helix and at least one cysteine substitution is located on the outside region of the alpha helix.

4. The peptide of claim 1 , wherein one cysteine substitution is located in the region of SEQ ID NO: 1 consisting of SEQ ID NO: 2.

5. The peptide of claim 2 comprising a Q13C substitution relative to amino acid sequence of SEQ ID NO: 1.

6. The peptide of claim 2 comprising an H6C substitution relative to amino acid sequence of SEQ ID NO:1.

7. The peptide of claim 1 comprising a H6C substitution relative to the amino acid sequence of SEQ ID NO:1.

8. The peptide of claim 1 comprising an Q13C or H6C substitution and at least one additional cysteine substitution at any other amino acid position relative to SEQ ID NO 1.

9. The peptide of claim 8 , wherein the at least one additional cysteine substitution is ≥1 and ≤11 amino acids relative to SEQ ID NO: 1.

10. The peptide of claim 1 comprising substitution of at least 3 amino acids of SEQ ID NO: 1 with cysteine.

11. The peptide of claim 10 , wherein the at least one cysteine substitution is ≥3 and ≤11 amino acids relative to SEQ ID NO: 1.

12. The peptide of claim 1 comprising the amino acid sequence of any one of SEQ ID NOS:3-109, or a variant thereof with at least 70% sequence identity thereto.

13. The peptide of claim 1 , wherein the peptide has the amino acid sequence of SEQ ID NO: 8 or a variant thereof with at least 70% sequence identity thereto.

14. A hair composition comprising a plurality of the peptide of claim 1 .

15. The composition of claim 14 comprising about 0.001% to about 25%, about 0.001% to about 20%, about 0.001% to about 15%, about 0.001% to about 10%, about 0.001% to about 5%, about 0.001% to about 1%, or about 0.01 to about 0.1% wt/wt of the peptide to the total weight of the hair composition.

16. A kit comprising the peptide of claim 12 .

Assignments (5)
RELEASE OF SECURITY INTEREST AT R/F 069264/0893 Recorded Jul 8, 2026
From: GOLDMAN SACHS BANK USA
To: OLAPLEX, INC.
Reel/Frame 075993/0373 →
SECURITY INTEREST Recorded Nov 14, 2024
From: OLAPLEX, INC.
To: GOLDMAN SACHS BANK USA
Reel/Frame 069264/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2023
From: PALONI, JUSTIN
To: PURVALA BIOSCIENCE, INC.
Reel/Frame 064162/0442 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXPUNGED SECOND ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 063683 FRAME: 0366. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jun 19, 2023
From: PURVALA BIOSCIENCE, INC.
To: OLAPLEX, INC.
Reel/Frame 064020/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2023
From: PURVALA BIOSCIENCE, INC.; OLAPLEX, INC.
To: OLAPLEX, INC.
Reel/Frame 063683/0366 →
Continuity (2)
Provisional Application 63205666 · Dec 19, 2020
Related Publication 20220226222A1 · Jul 21, 2022
Cited By (1)
US 12,303,583